Akebia Therapeutics, Inc. (AKBA) Revenue Growth
Akebia Therapeutics, Inc. (AKBA) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 11706.32% |
| 2018-12-31 | 14.63% |
| 2019-12-31 | 61.26% |
| 2020-12-31 | -11.85% |
| 2021-12-31 | -27.68% |
| 2022-12-31 | 36.94% |
| 2023-12-31 | -33.46% |
| 2024-12-31 | -17.70% |
| 2025-12-31 | 47.46% |
How AKBA compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| TXMD | TherapeuticsMD Inc. | 71.61% |
| RIGL | Rigel Pharmaceuticals Inc. | 64.15% |
| ARRY | Array Technologies Inc. | 40.22% |
| IONS | Ionis Pharmaceuticals Inc. | 33.83% |
| MOH | Molina Healthcare Inc | 11.75% |
These are five companies in the same sector as AKBA with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Akebia Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("AKBA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AKBA | $0.97 | -0.87% | 8.35M |
| 3 | ||||
| 4 | ||||
| 5 |